Over the last 180 days, Corvus Pharmaceuticals, Inc. insiders bought a net $333.7K of stock across 32 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 27 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| OPERATING INCOME | $-43.0M | $-27.5M | $-23.4M | $-32.6M |
| NET INCOME | $-15.3M | $-62.3M | $-27.0M | $-41.3M |
| EPS (DILUTED) | -0.53 | -1.02 | -0.56 | -0.89 |
| OPERATING CASH FLOW | $-32.8M | $-25.4M | $-23.9M | $-27.0M |
| CASH | $4.6M | $8.7M | $12.6M | $13.2M |
| DIVIDENDS PAID | $0 | $0 | $0 | — |
No password to create and no card required. We store your email address and nothing else.